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INTRODUCTION
Angiogenesis, generation of new microvessels from preexi-
sting blood vessels, is essential for tumor growth and invasion
(1). Cancer cells stimulate angiogenesis by secreting angioge-
nic growth factors and cytokines, such as vascular endothelial
growth factor (VEGF), platelet derived growth factor (PDGF),
and fibroblast growth factor (FGF) that act on the endothelial
cells of adjacent vessels and microvessels (2). Angiopoietins,
a new family of angiogenic growth factors that are mostly
specific for the vascular endothelium, have been identified in
recent years (3-5). Angiopoietins have been shown to func-
tion as ligands for the Tie2/Tek vascular endothelial-specific
receptor (6, 7). Angiopoietin 1 (Ang-1) functions to stabilize
and maintain mature vessels by promoting interaction between
endothelial cells and its supporting cells such as pericytes and
smooth muscle cells (8, 9). Angiopoietin 2 (Ang-2) is expre-
ssed at sites of vascular remodeling and is thought to play a
facilitating role at sites of vascular remodeling by disrupting
the constitutive stabilizing action of Ang-1 (5). 
Gastric cancer is the second most common malignancy in
the world. It has been demonstrated that certain cancer cells
(e.g. breast, stomach) produce several angiogenic growth
factors, including VEGF, PDGF and transforming growth
factor  1 (TGF- 1) and the expression of these factors cor-
relate with tumor angiogenesis, tumor progression and poor
prognosis (2, 10-12). Among the known angiogenic factors,
VEGF has emerged as the central regulator of the angiogenic
process in cancer (2). Increased expression of VEGF in gas-
tric cancer has been demonstrated and it is correlated with
tumor angiogenesis and poor prognosis (11-13). However,
little is known about the expression of angiopoietins and Tie2
in gastric carcinoma and their relation to angiogenesis and
clinicopathologic findings. Angiopoietin receptors, Tie2/Tek,
were previously thought to be expressed exclusively by endo-
thelial cells (6, 7). Recently, some studies have suggested that
Tie2 could be expressed in hematopoietic precursors and can-
cer cells (14, 15) and prostate carcinoma cells (16). However,
the possibility that angiopoietins/Tie2 are expressed in gas-
tric cancer and can function in an autocrine or paracrine man-
ner has not been previously examined.
In the present study we examined the expression and local-
ization of Ang-1 and Ang-2 mRNAs and proteins in human
gastric carcinomas and investigated the correlation between
angiogenesis and differentiation of carcinomas, lymph node
metastasis, tumor size, depth of invasion, and TNM staging. 
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Expression of Angiopoietin 1, 2 and Their Common Receptor Tie2 in
Human Gastric Carcinoma: Implication for Angiogenesis 
Angiogenesis, formation of new microvessels providing oxygen and nutrient supply,
is essential for tumor growth. It is dependent on the production of angiogenic growth
factors by tumor cells. Angiopoietin 1 (Ang-1) and 2 (Ang-2) and their common
receptor, Tie2, are thought to be critical regulators of tumor angiogenesis. We exam-
ined expression of Ang-1, Ang-2, and their common receptor Tie2 mRNAs and
proteins in gastric cancers using in situ hybridization and immunohistochemistry.
We also investigated the relationship between their expression and differentiation
of cancer cells, lymph node metastasis, tumor size, depth of cancer cell invasion,
TNM staging and microvessel density (MVD). The expression of Ang-1, Ang-2,
and Tie2 mRNA in cancer cells significantly correlated with the MVD (p<0.001,
<0.001 and =0.019, respectively). Ang-1 and Tie2 positivity correlated with advanced
gastric cancers (p<0.05) and larger cancers had higher positive rates of Ang-1, Ang-
2, and Tie2 mRNA expression (p<0.001, =0.010 and =0.039, respectively). Signifi-
cant positive correlations were also found between mRNA expression of Tie2 and
those of Ang-1 and Ang-2 (p<0.01 and <0.001, respectively). These findings indi-
cate that the expression of Ang-1 and Ang-2 is important for tumor angiogenesis,
and suggest a possible role of autocrine/paracrine function of angiopoietin/Tie2
system in gastric cancer progression.
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MATERIALS AND METHODS
Patients and specimen
The Human Ethics Committee of Chonbuk National
University Medical School approved this study. We used
gastric cancer specimens obtained from 51 patients (between
1998 and 1999) at Chonbuk National University Hospital
who underwent curative gastrectomy without prior chemo-
therapy or radiation therapy. There were 35 male patients and
16 female patients with ages ranging from 34 to 76 yr (mean,
60.2 yr). Clinicopathologic data obtained included histologi-
cal type of gastric cancer, differentiation, lymph node meta-
stasis, size of tumor, and post-operative TNM staging. The
pathologic findings were determined according to guidelines
established by the Japanese Society Committee on Histologi-
cal Classification of Gastric Cancer (17). The TNM staging
was determined based on criteria of the American Joint Com-
mittee on Cancer (AJCC) (18). The cases have included 38
tubular adenocarcinomas and 13 signet ring cell carcinomas.
In 38 cases diagnosed as tubular adenocarcinoma, there were
2 cases of well differentiated, 18 cases of moderately differen-
tiated and 18 cases of poorly differentiated adenocarcinoma. 
In situ hybridization for angiopoietin 1, 2 and Tie2
Tissue detection of the mRNAs for human Ang-1, Ang-2,
and Tie2 were performed using in situ hybridization. Paraf-
fin-embedded sections and digoxigenin-labeled sense and
anti-sense RNA probes were used. The human Ang-1, Ang-
2, and Tie2 RNA probes were generated from linearized
pBluescript II KS+ plasmid (Stratagene, La Jolla, CA, U.S.A.),
which contains an Hind III-Eco RI fragment corresponding
to nucleotides 396 through 809 of the human angiopoietin-1
cDNA, a Xho I-Bam HI fragment corresponding to nucleo-
tides 638 through 920 of the human angiopoietin-2 cDNA,
and an Hind III-Xbal fragment corresponding to nucleotides
511 through 668 of the human Tie2 cDNA, respectively.
Digoxigenin-labeled RNAs were synthesized using a DIG
RNA Labeling kit (Boehringer Mannheim, Indianapolis,
IN, U.S.A.). Sections were preincubated in mRNA in situ
hybridization solution (DAKO, Carpinteria, CA, U.S.A.).
Hybridization was carried out overnight at 55℃in a humid-
ified chamber. The concentration of hybridization mixture
was 0.5 ng RNA probe per 1  L of mRNA in situ hybridiza-
tion solution used for the prehybridization step. Posthybridi-
zation wash was performed at 53℃ in 0.1×stringent wash
solution (DAKO, Carpinteria, CA, U.S.A.). After blocking
the nonspecific protein binding with Protein Block Serum-
Free (DAKO), the mRNA signals were detected using anti-
digoxigenin/alkaline phosphatase (DIG/AP) antibody and
bromochloroindoylphosphate/nitrobluetetrazolium (BCIP/
NBT) chromogen substrate (DAKO). Sense probes were used
as negative controls and staining evaluation was performed
under the same conditions. The extent of angiopoietin and
Tie2 staining were recorded using a grading system, based
on the percentage of cancer cells positively stained: grade
0=0-10% cells; grade 1=11-70% cells; grade 2=>70% cells
positively stained. When the positive cells were more than
10%, we regarded it as positive.
Immunohistochemistry 
For immunohistochemical staining, the immunoperoxi-
dase method was used with the streptoavidin-biotinylated
horseradish peroxidase complex (DAKO). Four  m thick
sections were cut from the formalin-fixed and paraffin-embed-
ded tissue blocks. For angiopoietin 1 and angiopoietin 2
immunostaining, sections were treated with target retrieval
solution (DAKO) for 20 min at 97℃, and then incubated
in methanol containing 0.3% hydrogen peroxide at room
temperature for 20 min to block endogenous peroxidase.
Subsequently, sections were incubated with Protein Block
Serum-Free (DAKO) at room temperature for 10 min and
were then incubated for 2 hr at room temperature with anti-
factor VIII related antigen antibody (DAKO), which stains
only endothelial cells, or overnight at 4℃with anti-angiopoi-
etin 1, 2 or Tie2 (Chemicon International, Temecula, CA,
U.S.A.) primary antibodies. After washing, the sections were
incubated with a biotin-conjugated secondary antibody at
room temperature for 30 min and finally with peroxidase
conjugated streptoavidin at room temperature for 30 min.
Peroxidase activity was detected with the enzyme substrate
3 amino-9-ethyl carbazole. Sections treated the same way
described above, except they were incubated with Tris buffered
saline instead of the primary antibody, served as the negative
controls.
Determination of microvessel density
Sections stained for factor VIII related antigen, which visu-
alizes endothelial cells, were used for determination of micro-
vessel density (MVD). Sections were screened under ×40
magnification to identify the areas with the highest vascular
density within the tumor. Microvessels were counted in 4
areas under ×200 magnification. Any single stained cells
or cluster of endothelial cells that were clearly separated from
adjacent microvessels, tumor cells, and other connective tis-
sue elements were considered as vessels. 
Statistical analysis
The relationship between expression of Ang-1, Ang-2,
and Tie2 mRNA, and microvessel density was analyzed
using Student’s t-test. Associations between the expression
of Ang-1, Ang-2, and Tie2 mRNA, and clinicopathologic
factors were tested by chi-square test. The following clinico-
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expression: age, sex, differentiation of cancer cells (differen-
tiated; well and moderately differentiated carcinomas vs.
undifferentiated; poorly differentiated and signet ring cell
carcinomas), tumor depth (early gastric cancer [Tis, carcino-
ma in situ; T1, tumor invades lamina propria or submucosa]
vs. advanced gastric cancer {T2, tumor invades the muscu-
laris propria or the subserosa; T3, tumor penetrates the serosa
without invading adjacent structures; T4, tumor invades
adjacent structures]), lymph node metastasis, size of tumor
(<2 cm vs. ≥2 cm) (19), and post-operative TNM staging
(I+II vs. III+IV). A p-value of less than 0.05 was considered
significant.
RESULTS
Angiopoietin-1, Angiopoietin-2 and Tie2 expression and
localization
Ang-1 mRNA was expressed in 30 of 51 specimens (58%);
Fig. 1. (A-E) In situ hybridization for Ang-1, Ang-2 and Tie2 mRNA. (A) Positive Ang-2 expression in well-differentiated cancer cells (arrow-
heads) with no or only minimal staining on adjacent metaplastic gastric mucosa (arrows) (×100). (B) Moderately differentiated cancer cells
show intense cytoplasmic staining for Ang-2 mRNA (×200). (C) Positive Ang-1 mRNA signals on cancer cells (arrowheads, ×100) as
well as smooth muscle cells and endothelial cells of large vessels (arrows, Inset, ×400). (D) Poorly differentiated cancer cells (arrowheads)
and endothelial cells (arrow) show Tie2 mRNA expression (×100). (Continued on next page)
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9 tumors were grade 1 (11-70% cells positively stained),
and 21 were grade 2 (>70% cells positively stained). Ang-2
mRNA was expressed in 25 of 51 specimens (49%); 8 tumors
were grade 1, and 17 were grade 2. Tie2 mRNA was exp-
ressed in 10 of 51 specimens (19%); 7 were grade 1, and 3
were grade 2. All ten Tie2 mRNA positive specimens exp-
ressed Ang-1 mRNA, Ang-2 mRNA or both. Ang-1 and
Ang-2 mRNA were mainly expressed in cancer cells as a
strong cytoplasmic staining (Fig. 1A, B). No or minimal
staining was observed in normal and metaplastic gastric
mucosal cells (Fig. 1A). In addition to the strong staining
present in carcinoma cells, smooth muscle cells of large ves-
sels, occasional stromal cells and endothelial cells demon-
strated positive staining for Ang-1 mRNA (Fig. 1C). Occa-
sionally, endothelial cells of blood vessels expressed Ang-2
mRNA. Tie-2 mRNA was mainly expressed in infiltrating
cancer cells of undifferentiated group and in endothelial cells
(Fig. 1D, E). Expression of Tie2 mRNA was predominantly
confined to T2-4 classification and carcinomas of undiffer-
entiated group. No specific staining was present when the
Fig. 1. (Continued from the previous page) (E) Infiltrating poorly differentiated carcinoma cells of the muscle layer (arrowheads, ×100)
show positive cytoplasmic Tie2 mRNA expression (Inset, ×400). (F-H) Immunohistochemistry for Ang-1, Ang-2 and Tie2 protein. (F) Mod-
erately differentiated cancer cells exhibit Ang-2 protein expression (×200). (G) Immunoreactivity for Ang-1 on smooth muscle cells of ves-
sels (arrows), stromal cells and cancer cells (arrowheads) (×200). (H) Immunohistochemistry for Tie 2. Same cancer area to Fig. E (×100)
shows positive cytoplasmic expression on tumor cells (Inset, ×400).
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sense probes were used. We selected the 10, 10, and 5 rep-
resentative gastric carcinoma specimens with a strong Ang-1,
Ang-2 and Tie2 mRNA expression and performed immunos-
taining for Ang-1, Ang-2 and Tie2 proteins in order to com-
pare localization of proteins and mRNAs. Immunostaining
with polyclonal antibodies specific for human Ang-1, Ang-
2 and Tie2 showed that localization of these proteins and
respective Ang-1, Ang-2 and Tie2 mRNA was very similar
in all specimens (Fig. 1F-H).
Statistical results
The microvessel counts in gastric cancer specimens ranged
from 5 to 71 with a mean value of 27.7 (standard deviation,
16.3). Ang-1, Ang-2 and Tie2 mRNA expression significantly
correlated with the MVD. Table 1 shows the correlation bet-
ween MVD and Ang-1, Ang-2 and Tie2 mRNA expression.
Large gastric cancers (≥2 cm) had a significantly higher
positive rate of Ang-1, Ang-2 and Tie2 mRNA expression
than small-sized (<2 cm) ones (Table 2). The Ang-1 and Tie
2 positive rates were also higher in T2-4 cancers than those
of Tis and T1 cancers. A strong correlation was found between
Ang-1 and Ang-2, and Tie2 mRNA expression (p=0.002,
and p<0.001, respectively). There was no close correlation
between the expression of these angiogenic factors and sex,
age, tumor stage, histologic types of cancer, and lymph node
metastasis. Although there was a tendency for higher Tie2
mRNA expression in carcinomas of undifferentiated group
compared with the carcinomas of differentiated group, this
correlation was not statistically significant (p=0.165). 
DISCUSSION
In the majority of cancers, tumor growth is critically depen-
dent on blood vessels because of the requirement for increased
nutrient and oxygen supply. Cancer cells can induce the for-
mation of new blood vessels from pre-existing ones through
the process of angiogenesis (1, 2). This process is controlled
by several angiogenic factors, including acidic and basic FGF,
VEGF, PDGF, TGF, and angiopoietins (2-5, 8-13). Ang-1
and its naturally occurring antagonist, Ang-2, regulate tyro-
sine phosphorylation of Tie2/Tek receptors on endothelial
cells (3-9). Several studies have demonstrated the important
role of angiopoietins as a mediator of angiogenesis in various
tumors, such as breast, colon, brain, liver and lung cancers
(20-27). In gastric cancer, the relationship between expres-
sions of angiopoietin and angiogenesis, or clinicopathologic
findings has not been fully examined.
Our study showed that the proportion of gastric cancers
expressing Ang-1, Ang-2, and Tie2 is significantly higher
in advanced cancers, and in larger size tumors. Furthermore,
expression of these angiogenic factors significantly correlat-
ed with tumor MVD. Our findings are consistent with the
result of Etoh et al. (28), who reported that Ang-2 mRNA
levels correlated with more advanced stages and more fre-
quent vascular involvement in gastric cancer. In other types
of cancer, for example, brain, liver, and lung cancer, high
expression of Ang-1 and Ang-2 correlated positively with
*Student’s t-test.
Number of 
gastric cancer
specimens
Number of
microvessels
(Mean±SD) in
tumor
*Signifi-
cance
Angiopoietin 1
Positive 30 34.3±14.1 p<0.001
Negative 21 15.4±8.5
Angiopoietin 2
Positive 25 34.9±12.4 p<0.001
Negative 26 18.5±13.4
Tie 2
Positive 10 38.4±11.2 p=0.019
Negative 41 25.1±16.4
Table 1. Correlation between microvessel density (expressed
as the total number of microvessel per area of four ×200 micro-
scopic fields) and Ang-1, Ang-2 and Tie2 mRNA expression in
gastric cancer cells
Variables
Angiopoie-
tin-1
Posi-
tive
Nega-
tive
Angiopoie-
tin-2
Posi-
tive
Nega-
tive
Tie2
Posi-
tive
Nega-
tive
Age (yr)
<55 7 6 6 7 3 10
≥55 23 15 19 19 7 31
Sex
Male 20 15 18 17 6 29
Female 10 6 7 9 4 12
Histological type
WD tubular adenoca 1 1 1 1 0 2
MD tubular adenoca 9 9 7 11 2 16
PD tubular adenoca 14 4 10 8 6 12
Signet ring cell Ca 6 7 7 6 2 11
T classification
Tis and T1 8* 12 8 12 1* 19
T2-T4 22 9 17 14 9 22
Lymph node
Metastasis + 18 7 15 10 6 19
Metastasis - 12 14 10 16 4 22
Tumor size (cm)
<2 2
� 10 2* 10 0* 13
≥2 28 1 23 16 10 28
TNM stage
I and II 17 14 15 16 6 25
III and IV 13 7 10 10 4 16
Table 2. Comparison of clinicopathologic features with Ang-1,
Ang-2 and Tie2 mRNA expression
WD, well differentiated; MD, moderately differentiated; PD, poorly differ-
entiated; adenoca, adenocarcinoma; Ca, carcinoma.
2 test. *, p<0.05; 
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tumor angiogenesis and tumor growth (22, 24, 25, 27, 29).
However, this issue remains somewhat controversial. Hayes
et al. reported that in breast cancer overexpression of Ang-1
did not enhance tumor growth (20). Another study showed
a significant reduction in expression of angiopoietins in breast
cancers compared with that of normal breast tissue (26). Our
present data support the contention that angiopoietins and
their receptor Tie2 play an important role in gastric cancer
angiogenesis and cancer growth.
While the role of Tie2 receptor and angiopoietins in devel-
opmental angiogenesis has been intensively studied, little is
known about their expression and function in malignant cells.
Although the precise function of Tie2 expressed in tumor
cells remains unclear, our findings of Tie2 expression in gas-
tric cancer cells is particularly interesting in light of recent
observations that Tie2 can be expressed by certain types of
tumor cells, hematopoietic, prostate cancer and giant cell
tumors of tendon sheath (14-16, 30). Certain angiogenic
factors, such as FGF-1 and VEGF, have receptors distribut-
ed not only in tumor cells, but also in surrounding stromal
cells and endothelial cells of vessels. This distribution sug-
gests the possible paracrine or autocrine regulation of tumor
growth by angiogenic factors (10, 31). In our present study,
some specimens showed that cancer cells, as well as endothe-
lial cells, express Tie2. The expression of Tie2 was signifi-
cantly associated with large size tumors, advanced gastric
cancer, and increased MVD. Moreover, a strong correlation
was found between Ang-1, Ang-2, and Tie2 mRNA expres-
sion. Emerging evidence suggests that the autocrine activity
of VEGF could be important for tumor cell survival, and
growth (10, 32, 33). Recently, Soker et al. (32) reported that
the expression of VEGF receptors by prostate tumor cells
correlates with progression to a more malignant phenotype,
and increased chemotactic migration of FB2 prostate tumor
cells, and suggested an autocrine signaling loop involving
VEGF and its receptor. Our findings are consistent with the
recent paper of Nakayama et al. (34), who reported that Tie
receptors and angiopoietins were highly expressed in human
gastric adenocarcinoma cells and the Tie-Ang receptor-ligand
complex is one of the factors involved in the progression of
human gastric adenocarcinoma. In our study, we found that
Tie2 expression was mainly confined to advanced, undiffer-
entiated carcinomas. While a functional role for Tie2 recep-
tor expression in tumor cells has not been reported, our obser-
vation suggests that the Tie2 receptor may be related to tumor
progression or dedifferentiation of gastric cancer cells. Fur-
ther analysis of Tie2 expression by cancer cells is required to
determine its mechanism of action and whether Tie2 has an
important role in gastric cancer progression.
In summary, our findings indicate that expression of Ang-1
and Ang-2 is associated with and most likely related to in-
creased angiogenesis and tumor growth in human gastric
cancers. The expression of both angiopoietins and their Tie2
receptor in gastric cancer cells suggests a possible autocrine/
paracrine regulation of gastric cancer cell growth and may
be involved in the emergence of an aggressive phenotype
during gastric cancer progression.
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